Document Detail

Increased aldehyde reductase expression mediates acquired radioresistance of laryngeal cancer cells via modulating p53.
MedLine Citation:
PMID:  22555805     Owner:  NLM     Status:  Publisher    
The main obstacle to cure tumors by radiotherapy has been ascribed to tumor radioresistance. To determine the mechanisms underlying resistance to irradiation, it is essential to compare proteins differentially expressed from radiotherapy-sensitive and -resistant cancer cells. Aldehyde reductase (AKR1A1) was recently identified as increased in radioresistant laryngeal cancer cells by comparative proteomics approach. Here, we provide the mechanism of AKR1A1-mediated radioresistance via p53 regulation in laryngeal cancer cells. AKR1A1 induction was correlated with the radioresistant phenotype of laryngeal cancer HEp-2 cells. AKR1A1 depletion with siRNA significantly enhanced radiation sensitivity of radioresistant HEp-2 cells by promoting radiation-induced cell death and accelerated radiation-mediated inhibition of cell proliferation, without affecting either the PI3K-Akt or MAPK-ERK pathways. Intriguingly, AKR1A1 depletion induced phosphorylation of p53 at serine 15 and G 2/M transition in response to irradiation. We further found that AKR1A1 interacted with p53 and this interaction was dramatically increased in the irradiated radioresistant cells compared with the control cells. AKR1A1 expression also regulated p53 stability in response to irradiation. Furthermore, AKR1A1 depletion only sensitized HCT116 cells expressing p53 to irradiation and not p53-deficient cells. Therefore, our data suggest that radiation-inducible AKR1A1 contributes to acquired radioresistance of laryngeal cancer cells by suppressing p53 activation through inhibitory interaction.
Jae-Sung Kim; Jong Wook Chang; Jong Kuk Park; Sang-Gu Hwang
Related Documents :
2559815 - Isolation of an aggregation-less mutant of dictyostelium discoideum with the expression...
22812695 - Reversal of paclitaxel resistance in epithelial ovarian carcinoma cells by a muc1 aptam...
25426615 - The ace2-angiotensin-(1-7)-mas axis protects against pancreatic cell damage in cell cul...
10504325 - Assessing the role of the asp56/cap homologue of dictyostelium discoideum and the requi...
12229935 - Determination of the fraction of s-phase cells in root meristems using bromodeoxyuridin...
15488535 - A framework for whole-cell mathematical modeling.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-01
Journal Detail:
Title:  Cancer biology & therapy     Volume:  13     ISSN:  1555-8576     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-5-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101137842     Medline TA:  Cancer Biol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Radiation Cancer Research; Korea Institute of Radiological and Medical Sciences; Seoul, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a pote...
Next Document:  EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for Eph...